Welcome to Shanghai Probechem Biochemicals Co Ltd !Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : eEF-2K inhibitor 2C
Catalog No.: PC-20825Not For Human Use, Lab Use Only.
eEF-2K inhibitor 2C (Compound 2C) is a small molecule inhibitor of eukaryotic elongation factor 2 kinase (eEF-2K), binds to the ATP-binding site of eEF-2K.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
eEF-2K inhibitor 2C (Compound 2C) is a small molecule inhibitor of eukaryotic elongation factor 2 kinase (eEF-2K), binds to the ATP-binding site of eEF-2K.
eEF-2K inhibitor 2C (Compound 2C) (−7.691 kcal/mol) has better docking scores than some of the published eEF-2K inhibitors such as nonpotent inhibitor A484954 (−5.621 kcal/mol), NH125 (−4.503 kcal/mol), and TX-1918 (−5.533 kcal/mol), except for nonspecific eEF-2K inhibitor Rottlerin (−8.263 kcal/mol).
eEF-2K inhibitor 2C (Compound 2C) (<1 uM) inhibits proliferation and colony formation in breast cancer cells, including highly aggressive and invasive TNBC cells such as MDA-MB-231 (p53- and Kras-mutated), BT-20 (PI3K- and p53-mutated), and MDA-MB-436 (p53- and BRCA1-mutated) and noninvasive MCF-7 (ER+) cells.
eEF-2K inhibitor 2C (Compound 2C) inhibits activity of eEF-2K as indicated by reduced phosphorylation of its downstream target EF2, induces apoptosis in TNBC cells.
Treatment with single-lipid nanoparticle incorporating eEF-2K inhibitor 2C (Compound 2C) (20 mg/kg) significantly inhibited tumor growth, led to significant reduction in eEF-2K activity as indicated by reduced levels of p-EF2 (Thr56) in MDA-MB-231 tumor xenographs in highly aggressive TNBC tumor models.
| M.Wt | 344.29 | |
| Formula | C19H11F3O3 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Ferah Comert Onder, et al. ACS Pharmacol Transl Sci. 2021 Mar 30;4(2):926-940.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
